A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)
NCT06626464 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2026-04-13
Summary
The purpose of this study is to learn what happens to elpipodect in a healthy person's body over time.
Conditions
- Healthy
Interventions
- DRUG
-
[14C]Elpipodect
Oral administration
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Merck Sharp & Dohme LLC
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-13
- Primary Completion
- 2022-07-08
- Completion
- 2022-07-08
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants
NCT05567510 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects
NCT01818232 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants
NCT06088264 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
NCT05981963 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)
NCT06658626 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects
NCT04655898 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356
NCT04147910 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants
NCT01949610 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of MK-8266 (MK-8266-001)
NCT01025791 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Metabolism and Excretion, and Absolute Bioavailability of BMS-986365 in Healthy Male Participants
NCT06433505 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants
NCT06640920 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects
NCT01503866 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects
NCT04654897 ·Status: COMPLETED ·Phase: PHASE1
-
Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
NCT06691828 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects
NCT01487239 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male Participants
NCT02692677 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants
NCT03864601 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants
NCT06311786 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers
NCT04246749 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.
NCT04086719 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body
NCT03654170 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment
NCT04634149 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants
NCT03758339 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance and Metabolism Study of 14C-Z-215
NCT02618629 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects
NCT06670898 ·Status: COMPLETED ·Phase: PHASE1